Body Weight Considerations in the Management of Type 2 Diabetes-Reference-Cited by-同舟云学术

Body Weight Considerations in the Management of Type 2 Diabetes

Published:2018-11-21 Issue:1 Volume:36 Page:44-58
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Apovian Caroline M.^ORCID,Okemah Jennifer,O’Neil Patrick M.

Funder

Sanofi US, Inc.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s12325-018-0824-8/fulltext.html

Reference81 articles.

1. Medical Research Council. Diabetes: facts and stats. https://www.mrc.ac.uk/documents/pdf/diabetes-uk-facts-and-stats-june-2015/ . Accessed June 2018.

2. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf . Accessed June 2018.

3. Scheen AJ, Van Gaal LF. Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes. Lancet Diabetes Endocrinol. 2014;2:911–22.

4. Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34:1481–6.

5. Ross SA. Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes. Am J Med. 2013;126(9 Suppl 1):S38–48.

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypharmacy and its associated factors among patients with co-morbid hypertension and diabetes in a municipal hospital in Ghana;Scientific African;2024-03

2. The Role of Obesity in Type 2 Diabetes Mellitus—An Overview;International Journal of Molecular Sciences;2024-02-04

3. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis;BMJ;2024-01-29

4. Construction and Identification of a Breast Bioreactor for Human-Derived Hypoglycemic Protein Amylin;Life;2024-01-28

5. Predictors of weight reduction effectiveness of SGLT2 inhibitors in diabetes mellitus type 2 patients;Frontiers in Endocrinology;2024-01-24